PSCA antibody
Quick Overview for PSCA antibody (ABIN271792)
Target
See all PSCA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity (Details)
-
Species reactivity (expected):Mouse.
Species reactivity (tested):Human. -
Purification
- Affinity Chromatography using epitope-specific immunogen.
-
-
-
-
Application Notes
-
ELISA: 1: 20000approx. 1: 40000. WB: 1: 500approx. 1: 1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS, pH ~7.2, 0.05 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid freeze-thaw cycles.
-
-
- PSCA (Prostate Stem Cell Antigen (PSCA))
-
Alternative Name
- PSCA
-
Background
- Prostate stem cell antigen (PSCA) is a 123 amino acid glycosylated protein that shares homology with the Thy-1/Ly-6 family of glycosyl-phosphatidylinositol GPI)-anchored cell surface antigens. The PSCA gene maps to chromosome 8q24.2 and transcripts are most prevalent in prostate and placenta. The gene encoding c-myc is also located on chromosome 8q and like PSCA, is overexpressed in a large number of prostate cancers. Transcripts for PSCA are also abundant in urothelial tumors, and levels of PSCA transcripts increase in confluent RT112 bladder carcinomas, suggesting that PSCA is a marker for urothelial and gastric tissue carcinogenesis. Among prostate cancer cell surface antigens, PSCA is expressed in over 80 % of prostate carcinomas and correlates well to certain prostate cancer phenotypes such as prostate cancer bone metastates.Synonyms: Prostate stem cell antigen
-
Molecular Weight
- approx. 29 kDa
-
Gene ID
- 9606
-
UniProt
- O43653
Target
-